s.grigorescu
TL2 Member · Chania, GR
Practical questions, practical answers. Not interested in speculation without a source.
Joined 11 July 2025 · last posted 6d
74 posts, newest first. Showing up to 150.
-
Request: a per-category review queue Replied, post #123 · Meta › Feature requests · 22 Jul 2026 · 26 likes post #122 is right about the mechanism and I think understates the practical bit. Deprecation requests: if you think a feature should be removed or changed, that is…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #108 · Compounds › Semaglutide · 17 Jul 2026 · 10 likes The SELECT trial changed the positioning because it was the first cardiovascular outcome trial in people without diabetes. That decoupled the cardiovascular argument…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #38 · Pharmacology › Receptor biology · 8 Jul 2026 · 20 likes Amylin receptor signalling: amylin promotes satiety and slows gastric emptying through a receptor distinct from GLP-1. The hypothesis behind combination therapy is two…
-
Personal or family history of medullary thyroid carcinoma Replied, post #11 · Safety › Contraindications · 24 Jun 2026 · 3 likes post #10 is right about the mechanism and I think understates the practical bit. Gastroparesis or severe delayed gastric emptying: these compounds slow gastric…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — does this still hold? Replied, post #29 · Sourcing › Independent verification · 19 Jun 2026 · 11 likes post #28 answers the question as asked. The question underneath it is different. PeptideMeter: purity analysis plus structured, dated supplier verification records.…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #19 · Access › International · 16 Jun 2026 · 2 likes Language barriers: if you need to communicate with a supplier, clinician, or regulator in a language not your first language, misunderstanding is possible. Clarify when…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #79 · Evidence › Preprints · 14 Jun 2026 · 22 likes On post #75 — agreed on the reasoning, with one qualification. How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint]. Posted…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #83 · Sourcing › Vendor reports · 13 Jun 2026 · 30 likes Lot matching: confirm the lot number on the certificate matches the lot number on the vial. A result from a different lot is not evidence about your vial.
-
Follow-up: Reading an interaction checker output critically Replied, post #4 · Practice › Interactions · 12 Jun 2026 · 6 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #23 · Analytics › HPLC & UHPLC · 11 Jun 2026 · 2 likes Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar stationary phase and eluted by increasing organic solvent. For peptides the mobile…
-
Heart failure with preserved ejection fraction: symptom endpoints Replied, post #2 · Clinical › Comorbidities · 11 Jun 2026 · 5 likes Comorbidity control: if a comorbidity (high blood pressure, high lipids) is not adequately controlled, the decision about adding compounds in this class depends on the…
-
Does a peptide degrade silently, with no visual change? Replied, post #42 · Practice › Storage & stability · 6 Jun 2026 · 3 likes Protecting from light: amber vials or opaque containers reduce light exposure. If you are storing for long periods and light matters, this is worth doing. For…
-
Blind submission and why it changes minds — the long version Replied, post #107 · Sourcing › Independent verification · 30 May 2026 · 21 likes I read post #105 twice before replying, because I had assumed the opposite. Blind sampling: submitting without the laboratory or seller knowing the source removes the…
-
Follow-up: Sleep quality changes during weight loss Replied, post #30 · Wellbeing › Sleep · 26 May 2026 · 0 likes Appetite suppression and nighttime eating: if nighttime eating was a pattern, appetite suppression changes that pattern. Sleep can worsen if nighttime waking is…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #100 · Devices › Syringes & needles · 8 May 2026 · 0 likes Needle length: typical lengths for subcutaneous injection are 4-6 mm (short), 8 mm (standard), or 10-12 mm (longer). Longer needles are needed for deeper tissue or if…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #43 · Practice › Reconstitution · 8 May 2026 · 0 likes Picking up post #40: that is the part I would want checked first. Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #113 · Compounds › Tirzepatide · 7 May 2026 · 32 likes Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly rather than through summarised claims. Reconstituted…
-
Tracking semaglutide's approved indications across jurisdictions, dated Replied, post #3 · Compounds › Semaglutide · 27 Apr 2026 · 1 like Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects. Slowing the stomach empties it feeds less food into the intestines at a time,…
-
Constipation management, with a dietitian's contribution Replied, post #56 · Practice › Side effects · 23 Apr 2026 · 32 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Second pass at: What pooling buys you and what it destroys Replied, post #35 · Evidence › Meta-analyses · 7 Apr 2026 · 0 likes Worth separating two things that post #31 runs together. Why forest plots are more informative than pooled numbers: they show the variation across studies, which tells…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #25 · Sourcing › Red flags · 2 Apr 2026 · 0 likes Unresponsiveness: a supplier that does not reply to reasonable requests for documentation or clarification is showing you something about how they operate.
-
Prescription portability between countries Started this topic · Access › International · 1 Apr 2026 · 0 likes Prescription portability between countries — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included,…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #45 · Data & Tools › Datasets · 1 Apr 2026 · 5 likes Using data in discussions: datasets are useful as reference points when someone claims something unusual. "I have not seen that reported in the data" is different from…
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #26 · Clinical › Bloodwork · 29 Mar 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #93 · Research Methods › N-of-1 designs · 23 Mar 2026 · 5 likes Sample size in n-of-1: you are the sample. Repeated measurements (weekly weighings, daily mood scores) increase the power to detect a real effect even though n=1.
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #78 · Research Methods › N-of-1 designs · 18 Mar 2026 · 15 likes Stopping rules: decide in advance when you will stop measuring (after a defined duration, after a defined number of measurements, or after a defined condition is met).…
-
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #48 · Analytics › Impurities & related substances · 26 Feb 2026 · 4 likes I read post #46 twice before replying, because I had assumed the opposite. Disulfide formation: if a peptide contains cysteine, it can form disulfide bonds with itself…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #48 · Practice › Dosing & titration · 17 Feb 2026 · 9 likes Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base from trials but is described by some people. The downside is that…
-
Five questions in one post gets you one answer — how to split them Replied, post #11 · Start Here › How to Ask · 11 Feb 2026 · 1 like Five questions in one post gets you one answer: the easiest one, usually not the one you needed most. Post them separately or pick the one that depends on the others…
-
The most useful thing you learned here that was not the answer you came for Replied, post #18 · Lounge › Off topic · 2 Feb 2026 · 0 likes Not a rules-free zone: the guidelines still apply. No phones, no Telegram, no endorsements of other communities. Just a relaxed bar for how directly the topic needs to…
-
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #5 · Analytics › HPLC & UHPLC · 2 Feb 2026 · 19 likes Area percent is not mass percent. It is a proportion of absorbance, weighted by each species' extinction coefficient. For closely related impurities the approximation…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #116 · Analytics › COA interpretation · 22 Jan 2026 · 2 likes This follows post #113 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #59 · Pharmacology › Pharmacokinetics · 14 Jan 2026 · 0 likes Picking up post #56: that is the part I would want checked first. Albumin binding: semaglutide binds albumin through a fatty side chain, which sequesters the free form…
-
Journal club: semaglutide in MASH, and surrogate endpoints Replied, post #3 · Evidence › Journal club · 28 Dec 2025 · 0 likes PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #25 · Practice › Side effects · 27 Dec 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Heterogeneity as information rather than as a nuisance Replied, post #16 · Evidence › Meta-analyses · 5 Dec 2025 · 28 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Documentation that appears only after payment Replied, post #92 · Sourcing › Red flags · 30 Nov 2025 · 13 likes Inability to trace lots: if you ask "where was this synthesised, by whom, under what conditions" and cannot get a clear answer, that is a red flag. Traceability is not…
-
A calculator that gives a right answer to the wrong question — does this still hold? Replied, post #28 · Data & Tools › Calculators · 22 Nov 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #4 · Meta › Site feedback · 18 Nov 2025 · 19 likes Search and findability: if you searched for something and did not find it, report what you searched for and what you expected to find. That helps improve indexing and…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #81 · Practice › Reconstitution · 13 Nov 2025 · 10 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #49 · Practice › Interactions · 13 Nov 2025 · 3 likes post #48 answers the question as asked. The question underneath it is different. Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin…
-
Prescription requirements and telehealth models Replied, post #6 · Sourcing › Regulatory · 8 Nov 2025 · 0 likes post #5 is right about the mechanism and I think understates the practical bit. Why this category is maintained as documentation, not as recommendations: the goal is…
-
Sleep tracking data and its considerable limitations Replied, post #127 · Wellbeing › Sleep · 29 Oct 2025 · 0 likes Sleep apnoea improvement: as weight is lost, sleep apnoea usually improves. The timeframe is weeks to months, not immediate. Improvement often is gradual rather than…
-
Particulates in a reconstituted solution: identifying the likely source Replied, post #14 · Analytics › Impurities & related substances · 16 Oct 2025 · 8 likes Residual solvents: traces of solvents used in purification. These are usually tested by gas chromatography, not by HPLC. A specification for residual solvents should be…
-
Documentation that materially improves an appeal's chances Replied, post #27 · Access › Insurance & coverage · 13 Oct 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
An orphaned page with no inbound links — the long version Replied, post #7 · Meta › Wiki maintenance · 8 Oct 2025 · 4 likes Picking up post #4: that is the part I would want checked first. Outdated external links: if a maintained page links to external sources and those links are broken or…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #66 · Practice › Side effects · 16 Sep 2025 · 1 like Gallbladder complications: rapid weight loss increases the risk of gallstone formation. The mechanism is not specific to this drug class. The risk is greatest in the…
-
Why oral semaglutide needs an absorption enhancer at all Replied, post #32 · Compounds › Oral incretins · 9 Sep 2025 · 7 likes Fasting instructions are not optional advice. Taking the tablet with food or with more than a sip of water measurably reduces absorption. This is the one compound in…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #123 · Practice › Storage & stability · 26 Aug 2025 · 0 likes Vial integrity: once a vial is entered with a needle repeatedly, the rubber closure degrades and the integrity fails. Using the same vial repeatedly over weeks or…
-
A request that was declined, and the reasoning — a second dataset Replied, post #74 · Documentation › Wiki requests · 13 Aug 2025 · 0 likes On post #70 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
Thyroid function tests during substantial weight change Replied, post #7 · Clinical › Bloodwork · 16 Jul 2025 · 18 likes Analytical imprecision: any measurement has an error margin. A small difference in consecutive tests is usually measurement noise, not a real change. Knowing the…
-
Counter-ion content and its effect on measured mass Replied, post #73 · Analytics › Mass spectrometry · 24 Jun 2025 · 0 likes Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is common and its mass is predictable from the base mass.
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #110 · Clinical › Comorbidities · 10 Jun 2025 · 6 likes Chronic kidney disease: compounds in this class have renal benefit in people with kidney disease. The benefit appears to be additive to other renal-protective agents,…
-
Follow-up: Tracking intake honestly when appetite is absent Started this topic · Nutrition & Training › Protein & intake · 31 May 2025 · 5 likes Tracking intake honestly when appetite is absent Writing it up because I had to work it out twice and would rather nobody else did. Longitudinal report with the method…
-
Lean mass preservation: what the evidence supports Replied, post #13 · Outcomes › Body composition · 12 May 2025 · 0 likes Changes during titration: measuring body composition during active titration is less useful than measuring after dose is stable. Titration causes fluid shifts that…
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #12 · Evidence › Journal club · 20 Mar 2025 · 24 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
-
Validating a method you did not develop — does this still hold? Replied, post #126 · Analytics › Method validation · 17 Mar 2025 · 33 likes I read post #124 twice before replying, because I had assumed the opposite. Robustness: the method gives consistent results when minor parameters vary. Tested by…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #64 · Sourcing › Vendor reports · 17 Mar 2025 · 0 likes post #63 answers the question as asked. The question underneath it is different. Date the report: when the analysis was done matters. Material can degrade in storage. A…
-
Charge states for a 4 kDa peptide, worked through Replied, post #113 · Analytics › Mass spectrometry · 15 Mar 2025 · 0 likes This follows post #110 rather than contradicting it. What mass accuracy establishes: the measured mass is consistent with a specific composition. What it does not…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #42 · Sourcing › Regulatory · 1 Mar 2025 · 4 likes post #41 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #2 · Practice › Interactions · 25 Feb 2025 · 20 likes Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be affected by the slowing of fat absorption during weight loss, but…
-
Scheduled maintenance and what will be unavailable Replied, post #43 · Meta › Announcements · 14 Feb 2025 · 0 likes Worth separating two things that post #39 runs together. Feedback to announcements: if you have feedback on an announced change (not a question, but your position) post…
-
The report format the maintainers ask for, and why each field is there — what changed… Replied, post #9 · Sourcing › Vendor reports · 10 Feb 2025 · 11 likes Worth separating two things that post #5 runs together. Lot matching: confirm the lot number on the certificate matches the lot number on the vial. A result from a…
-
Oxidation pathways for methionine and tryptophan Replied, post #32 · Analytics › Impurities & related substances · 28 Dec 2024 · 1 like post #31 answers the question as asked. The question underneath it is different. Residual solvents: traces of solvents used in purification. These are usually tested by…
-
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #16 · Evidence › Journal club · 18 Dec 2024 · 1 like SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
Fixed versus detachable needles: the trade-offs Replied, post #39 · Devices › Syringes & needles · 8 Dec 2024 · 1 like Worth separating two things that post #35 runs together. Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more legible for small…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #55 · Access › Insurance & coverage · 5 Dec 2024 · 0 likes Denial letters: the stated reason tells you exactly what to submit next. A denial is not final; it is a specification for an appeal. Reading the reason carefully and…
-
Coming back to: When to suspect the method rather than the sample Replied, post #28 · Analytics › Method validation · 4 Dec 2024 · 12 likes Picking up post #25: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
When to suspect the method rather than the sample Replied, post #41 · Analytics › Method validation · 24 Nov 2024 · 0 likes post #40 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
EMA product information as a primary source — does this still hold? Replied, post #2 · Regional › European Union · 14 Nov 2024 · 0 likes This follows the opening post rather than contradicting it. France: ANSM implements EU framework. Reimbursement has been narrower for weight management. Prescribing…
-
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #25 · Clinical › Comorbidities · 7 Oct 2024 · 4 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #58 · Sourcing › Independent verification · 14 Sep 2024 · 21 likes post #57 is right about the mechanism and I think understates the practical bit. Janoshik Analytical: chromatographic purity and mass-spectrometric identity on…
-
Revisiting: US compounding rules and how they changed Replied, post #9 · Regional › North America · 7 Sep 2024 · 0 likes Provincial formularies in Canada are published and are the correct source for coverage information. Coverage for weight management is less common than for diabetes.
-
Where the four-week escalation interval comes from, and what it is not Replied, post #6 · Practice › Dosing & titration · 25 May 2024 · 13 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…